The European respiratory journal
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Characterisation of patients with interstitial pneumonia with autoimmune features.
Mast cells in asthma: biomarker and therapeutic target.
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened.
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Where do we go from here? Clinical drug development in idiopathic pulmonary fibrosis.
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis.
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes.
